CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,354 | $575.96 | $780K | 21,520 |
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,603 | $577.01 | $925K | 19,917 |
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −601 | $577.93 | $347K | 19,316 |
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −400 | $579.04 | $232K | 18,916 |
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $580.03 | $23K | 18,876 |
| 2026-04-13 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 92,500 | ||
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −35 | $569.78 | $20K | 49,978 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −925 | $571.39 | $529K | 49,053 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −945 | $572.39 | $541K | 48,108 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,235 | $573.39 | $708K | 46,873 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,370 | $574.25 | $787K | 45,503 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,850 | $575.31 | $1.1M | 43,653 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,081 | $576.36 | $623K | 42,572 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,475 | $577.32 | $852K | 41,097 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −384 | $578.52 | $222K | 40,713 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $579.53 | $116K | 40,513 |
| 2026-04-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 55,000 | ||
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −442 | $567.24 | $251K | 49,571 |
Page 125 of 171 · 3,408 trades